Funding & Relocation for Cellexus Limited

Cellexus Limited, an ambitious Life sciences business has decided to leave its English base and relocate to Scotland.

Cellexus cited Scotland’s reputation as a life sciences hub as well as strong links with academia and the NHS as it moved operations from Cambridgeshire to Dundee. The innovative business received £250,000 of equity match funding from the Scottish Investment Bank, the investment arm of Scottish Enterprise.

Cellexus has a device which produces proteins from bacteria including yeast, e-coli and algae. While the company’s main market is pharmaceuticals and diagnostics the system could also be used in the food and biofuel industries. The company plans to use the funding from the Scottish Investment Bank to enhance its international sales and marketing programme.

Julia Brown, director of life and chemical sciences, Scottish Enterprise, said: “That Cellexus has chosen to move to Dundee from Cambridgeshire is testament to Scotland’s reputation as the location of choice for life sciences companies.  Cellexus is an innovative, forward-thinking company and we look forward to continuing to work with them to help them successfully up-scale and explore new markets, driving forward their ambitious growth plan.”